The Effect of Thiamine in Reducing the Symptoms of Bortezomib-Induced Peripheral Neuropathy in Patients with Multiple Myeloma
Background: Peripheral neuropathy is one of the most frequent side effects of bortezomib-based chemotherapy, which has the most important role in treatment of multiple myeloma. Various supplements including vitamin B group complex have been examined to prevent and treat bortezomib-induced peripheral...
Main Authors: | Valiollah Mehrzad, Ghazal Rafiaei |
---|---|
Format: | Article |
Language: | fas |
Published: |
Vesnu Publications
2020-02-01
|
Series: | مجله دانشکده پزشکی اصفهان |
Subjects: | |
Online Access: | http://jims.mui.ac.ir/index.php/jims/article/view/12320 |
Similar Items
-
Reduced weekly subcutaneous doses of bortezomib in combination with cyclophosphamide and dexamethasone for newly diagnosed multiple myeloma
by: Farzaneh Ashrafi, et al.
Published: (2020-01-01) -
Immune modulation therapy in the management of bortezomib-induced peripheral neuropathy
by: Jeter Ashley, et al.
Published: (2012-08-01) -
Effectiveness of bortezomib and bortezomib-containing programs FOR the treatment of recurrent and resistant multiple myeloma
by: T A Mitina, et al.
Published: (2010-07-01) -
Dorsal Column Degeneration after Bortezomib Therapy in a Patient with Multiple Myeloma
by: Tatsuro Joh, et al.
Published: (2009-10-01) -
Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients
by: Wang H, et al.
Published: (2016-01-01)